SESSION 12. REGULATORY ASPECTS FOR IMPLEMENTING ARTIFICIAL INTELLIGENCE IN PV

Artificial Intelligence for Pharmacovigilance
November, Thursday 20 | 14:10 - 14:30

Speakers

ROBERT BALL
FDA - Deputy Director | Office of Surveillance and Epidemiology (OSE)